Document is current

Any future updates will be listed below

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine

Crossref DOI link: https://doi.org/10.1007/s00277-017-3190-8

Published Online: 2017-11-23

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark